FDA — authorised 23 June 1995
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: approved
FDA authorised Valtrex on 23 June 1995
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 23 June 1995.
GLAXOSMITHKLINE holds the US marketing authorisation.